The Meb Faber Show - Better Investing cover image

Liz Simmie, Honeytree – A Quantamental Approach to ESG | #514

The Meb Faber Show - Better Investing

CHAPTER

ESG Investing and Exclusion of Pharmaceutical Companies

The speakers discuss their approach to ESG investing and why pharmaceutical companies are excluded from their portfolio due to price fixing scandals and concerns about impact ratings. They emphasize the importance of companies making positive impacts and describe their investment strategy and portfolio construction.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner